Triple

T14008563
Position Surface form Disambiguated ID Type / Status
Subject Moderna E337017 entity
Predicate developed P73 FINISHED
Object mRNA-1273
mRNA-1273 is a messenger RNA–based COVID-19 vaccine that instructs cells to produce the SARS-CoV-2 spike protein to elicit an immune response.
E1074406 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: mRNA-1273 | Statement: [Moderna, developed, mRNA-1273]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: mRNA-1273
Context triple: [Moderna, developed, mRNA-1273]
  • A. Vaxzevria COVID-19 vaccine
    Vaxzevria COVID-19 vaccine is a viral vector coronavirus vaccine created to prevent COVID-19 infection and severe disease in adults.
  • B. BNT162b2
    BNT162b2 is an mRNA-based COVID-19 vaccine, co-developed by BioNTech and Pfizer, that became one of the first widely authorized vaccines against SARS-CoV-2.
  • C. Sputnik V COVID-19 vaccine
    Sputnik V COVID-19 vaccine is a Russian-developed viral vector vaccine against COVID-19 that gained global attention as one of the first vaccines authorized for use during the pandemic.
  • D. Moderna
    Moderna is a biotechnology company best known for pioneering mRNA-based vaccines, including one of the first widely used COVID-19 vaccines.
  • E. mRNA vaccine
    An mRNA vaccine is a type of vaccine that uses a small piece of messenger RNA to instruct cells to produce a viral protein, triggering an immune response without using a live virus.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: mRNA-1273
Triple: [Moderna, developed, mRNA-1273]
Generated description
mRNA-1273 is a messenger RNA–based COVID-19 vaccine that instructs cells to produce the SARS-CoV-2 spike protein to elicit an immune response.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: mRNA-1273
Target entity description: mRNA-1273 is a messenger RNA–based COVID-19 vaccine that instructs cells to produce the SARS-CoV-2 spike protein to elicit an immune response.
  • A. Vaxzevria COVID-19 vaccine
    Vaxzevria COVID-19 vaccine is a viral vector coronavirus vaccine created to prevent COVID-19 infection and severe disease in adults.
  • B. BNT162b2
    BNT162b2 is an mRNA-based COVID-19 vaccine, co-developed by BioNTech and Pfizer, that became one of the first widely authorized vaccines against SARS-CoV-2.
  • C. Sputnik V COVID-19 vaccine
    Sputnik V COVID-19 vaccine is a Russian-developed viral vector vaccine against COVID-19 that gained global attention as one of the first vaccines authorized for use during the pandemic.
  • D. Moderna
    Moderna is a biotechnology company best known for pioneering mRNA-based vaccines, including one of the first widely used COVID-19 vaccines.
  • E. mRNA vaccine
    An mRNA vaccine is a type of vaccine that uses a small piece of messenger RNA to instruct cells to produce a viral protein, triggering an immune response without using a live virus.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d81c645c5c8190b1fd16a285a1b78a completed April 9, 2026, 9:38 p.m.
NER Named-entity recognition batch_69de2ed44f90819099ad08c09c066b56 completed April 14, 2026, 12:11 p.m.
NED1 Entity disambiguation (via context triple) batch_69fbaca5fb48819090fff1fd22e8a15c completed May 6, 2026, 9:03 p.m.
NEDg Description generation batch_69fbadc6cb2c8190bdf66ad1fa6dd392 completed May 6, 2026, 9:08 p.m.
NED2 Entity disambiguation (via description) batch_69fbb01071408190a85e5e9be0150593 completed May 6, 2026, 9:18 p.m.
Created at: April 9, 2026, 10:19 p.m.